We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
-12.43%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$73.9B
AUM Growth
-$12.4B
Cap. Flow
-$7.83B
Cap. Flow %
-10.58%
Top 10 Hldgs %
21.74%
Holding
2,664
New
311
Increased
910
Reduced
656
Closed
240

Top Buys

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$788M
2
UNP icon
Union Pacific
UNP
+$641M
3
ICLR icon
Icon
ICLR
+$463M
4
WFC icon
Wells Fargo
WFC
+$310M
5
CSX icon
CSX Corp
CSX
+$286M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$599M
2
ICE icon
Intercontinental Exchange
ICE
+$280M
3
PEP icon
PepsiCo
PEP
+$246M
4
FDX icon
FedEx
FDX
+$242M
5
CL icon
Colgate-Palmolive
CL
+$190M

Sector Composition

Rank Sector Weight
1 Technology 18.51%
2 Healthcare 14.98%
3 Financials 13.27%
4 Industrials 10.94%
5 Consumer Discretionary 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALPN
1701
DELISTED
Alpine Immune Sciences Inc
ALPN
$39K ﹤0.01%
+4,617
New +$39.8K
VRAY
1702
DELISTED
ViewRay, Inc.
VRAY
$39K ﹤0.01%
14,958
– –
APEN
1703
DELISTED
Apollo Endosurgery, Inc.
APEN
$39K ﹤0.01%
10,904
+4,762
+78% +$22.5K
HSKA
1704
DELISTED
Heska Corp
HSKA
$39K ﹤0.01%
+413
New +$44.6K
AUDC icon
1705
AudioCodes
AUDC
$252M
$38K ﹤0.01%
1,766
– –
BNY
1706
DELISTED
BlackRock New York Municipal Income Trust
BNY
– –
0
– –
CGBD icon
1707
Carlyle Secured Lending
CGBD
$741M
$38K ﹤0.01%
+3,055
New +$42.9K
KRO icon
1708
KRONOS Worldwide
KRO
$947M
$38K ﹤0.01%
2,102
– –
SBRA icon
1709
Sabra Healthcare REIT
SBRA
$5.34B
$38K ﹤0.01%
+2,726
New +$36.4K
UDMY
1710
DELISTED
Udemy
UDMY
$38K ﹤0.01%
3,766
– –
WDFC icon
1711
WD-40
WDFC
$3.1B
$38K ﹤0.01%
191
-11,756
-98% -$2.19M
CTEV
1712
Claritev Corp
CTEV
$458M
$38K ﹤0.01%
174
+110
+172% +$21.7K
CMLS
1713
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$38K ﹤0.01%
+4,996
New +$58.6K
BCRX icon
1714
BioCryst Pharmaceuticals
BCRX
$2.36B
$37K ﹤0.01%
3,567
– –
BH icon
1715
Biglari Holdings Class B
BH
$1.22B
$37K ﹤0.01%
309
+111
+56% +$14.9K
CHE icon
1716
Chemed
CHE
$7.18B
$37K ﹤0.01%
80
– –
GPRO icon
1717
GoPro
GPRO
$126M
$37K ﹤0.01%
6,782
+2,256
+50% +$16.5K
IBB icon
1718
iShares Biotechnology ETF
IBB
$9.53B
$37K ﹤0.01%
315
– –
INNV icon
1719
InnovAge Holding
INNV
$1.49B
$37K ﹤0.01%
+8,466
New +$44.2K
IOVA icon
1720
Iovance Biotherapeutics
IOVA
$2.77B
$37K ﹤0.01%
3,474
+117
+3% +$1.53K
MTX icon
1721
Minerals Technologies
MTX
$2.34B
$37K ﹤0.01%
+608
New +$38.9K
TDC icon
1722
Teradata
TDC
$2.54B
$37K ﹤0.01%
1,020
-913
-47% -$36.4K
TDOC icon
1723
Teladoc Health
TDOC
$1.21B
$37K ﹤0.01%
1,138
-111
-9% -$4.71K
UVE icon
1724
Universal Insurance Holdings
UVE
$1.25B
$37K ﹤0.01%
2,870
– –
APPS icon
1725
Digital Turbine
APPS
$1.73B
$36K ﹤0.01%
2,110
+979
+87% +$26.5K
67 68
69
70 71

Similar funds

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Mitsubishi UFJ Financial Group
Mitsubishi UFJ Financial Group Tokyo, Japan $62.1B AUM 41.06% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Lazard Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Lazard Asset Management held 2,664 positions worth $73.9B, down 14% from $86.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Lazard Asset Management withdrew a net $7.83B in Q2 2022, closing 240 positions and reducing 656 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $156M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lazard Asset Management opened a new position in Aspen Technology Inc worth $74.1M.

  • Lazard Asset Management's largest Q2 2022 buy was Aspen Technology Inc: 403,325 shares worth $74.1M.
  • Lazard Asset Management added most to Norfolk Southern in Q2 2022, an estimated $788M increase.
  • Lazard Asset Management's biggest Q2 2022 reduction was Medtronic, cutting an estimated $599M.
  • Lazard Asset Management fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $156M.
  • Lazard Asset Management's ten largest holdings make up 22% of its $73.9B portfolio in Q2 2022.
  • Lazard Asset Management opened 311 new positions and closed 240 in Q2 2022.
  • Lazard Asset Management's portfolio value fell 14% quarter-over-quarter to $73.9B.

Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.